These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 15359934)
1. [Hemorrhagic risk of drotrecogin alfa (activated) in severe sepsis]. Perrotin D Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():16-9. PubMed ID: 15359934 [No Abstract] [Full Text] [Related]
2. Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. Barton P; Kalil AC; Nadel S; Goldstein B; Okhuysen-Cawley R; Brilli RJ; Takano JS; Martin LD; Quint P; Yeh TS; Dalton HJ; Gessouron MR; Brown KE; Betts H; Levin M; Macias WL; Small DS; Wyss VL; Bates BM; Utterback BG; Giroir BP Pediatrics; 2004 Jan; 113(1 Pt 1):7-17. PubMed ID: 14702440 [TBL] [Abstract][Full Text] [Related]
3. Drotrecogin alfa: a role in emergency department treatment of severe sepsis? McLeay AM Emerg Med Australas; 2004 Aug; 16(4):324-35. PubMed ID: 15283720 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human activated protein C for severe sepsis. Kapur S; Kupfer Y; Tessler S N Engl J Med; 2001 Jul; 345(3):219-20; author reply 220-1. PubMed ID: 11463021 [No Abstract] [Full Text] [Related]
5. Efficacy and safety of recombinant human activated protein C for severe sepsis. Bernard GR; Vincent JL; Laterre PF; LaRosa SP; Dhainaut JF; Lopez-Rodriguez A; Steingrub JS; Garber GE; Helterbrand JD; Ely EW; Fisher CJ; N Engl J Med; 2001 Mar; 344(10):699-709. PubMed ID: 11236773 [TBL] [Abstract][Full Text] [Related]
7. Activated protein C for severe sepsis. Ely EW; Bernard GR; Vincent JL N Engl J Med; 2002 Sep; 347(13):1035-6. PubMed ID: 12324564 [No Abstract] [Full Text] [Related]
8. Recombinant human activated protein C, drotrecogin alfa (activated): a novel therapy for severe sepsis. Kanji S; Devlin JW; Piekos KA; Racine E Pharmacotherapy; 2001 Nov; 21(11):1389-402. PubMed ID: 11714212 [TBL] [Abstract][Full Text] [Related]
9. FDA approves first biologic treatment for sepsis. FDA Consum; 2002; 36(1):3. PubMed ID: 11881595 [No Abstract] [Full Text] [Related]
10. Conclusions: drotrecogin alfa (activated)--from bench to practical use at the bedside. Maki DG Am J Surg; 2002 Dec; 184(6A Suppl):S47-50. PubMed ID: 12521617 [No Abstract] [Full Text] [Related]
11. Drotrecogin alfa: a second look. More clinical trials in severe sepsis: mostly negative results. Prescrire Int; 2007 Feb; 16(87):7-9. PubMed ID: 17323514 [TBL] [Abstract][Full Text] [Related]
12. The use of drotrecogin alfa (activated) in severe sepsis during acute pancreatitis - two case studies. Machała W; Wachowicz N; Komorowska A; Gaszyński W Med Sci Monit; 2004 Jul; 10(7):CS31-6. PubMed ID: 15232511 [TBL] [Abstract][Full Text] [Related]
13. Identifying patients with severe sepsis who should not be treated with drotrecogin alfa (activated). Morris PE; Light RB; Garber GE Am J Surg; 2002 Dec; 184(6A Suppl):S19-24. PubMed ID: 12521614 [TBL] [Abstract][Full Text] [Related]
14. [Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis]. Heslet L; Nielsen JD; Schierbeck J; Andersen JS Ugeskr Laeger; 2004 Mar; 166(11):997-1002. PubMed ID: 15049234 [No Abstract] [Full Text] [Related]
15. Breakthrough found in treatment of severe sepsis. Clin Resour Manag; 2001 Jul; 2(7):107-9. PubMed ID: 11482248 [TBL] [Abstract][Full Text] [Related]
16. Role of activated protein C in the pathophysiology of severe sepsis. Dettenmeier P; Swindell B; Stroud M; Arkins N; Howard A Am J Crit Care; 2003 Nov; 12(6):518-24; quiz 525-6. PubMed ID: 14619357 [TBL] [Abstract][Full Text] [Related]
17. Management of patients with severe sepsis, treated by drotrecogin alfa (activated). Laterre PF; Heiselman D Am J Surg; 2002 Dec; 184(6A Suppl):S39-46. PubMed ID: 12521616 [TBL] [Abstract][Full Text] [Related]
18. Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis--practical aspects at the bedside and patient identification. Laterre PF; Wittebole X Crit Care; 2003 Dec; 7(6):445-50. PubMed ID: 14624684 [TBL] [Abstract][Full Text] [Related]
19. Steroids and drotrecogin alfa (activated) for severe sepsis. Steingrub JS Chest; 2003 Nov; 124(5):2033. PubMed ID: 14605088 [No Abstract] [Full Text] [Related]
20. [Questionable efficacy and safety of activated drotrecogin alpha (activated protein C) in the treatment of severe sepsis]. Bartelink AK Ned Tijdschr Geneeskd; 2006 Feb; 150(7):352-4. PubMed ID: 16523795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]